Bombay HC: National Security Justifies Denial of Police Clearance Certificate  ||  Bombay HC: Comic Remarks Without Malicious Intent Not Religious Insult  ||  J&K&L High Court: Scandalous Allegations Against Judicial Officers in Pleadings Impermissible  ||  P&H HC: Writ Petition Against Private Trust's Contractual Employment Dismissed  ||  Gujarat HC: Customary Divorce Entitles Daughter to Family Pension  ||  Calcutta HC: ECI's Prerogative to Deploy Central Employees as Counting Supervisors Upheld  ||  Calling the Situation Grim, the Supreme Court Takes Suo Motu Cognizance of Delays in NCLT Approvals  ||  Supreme Court: Admission of a Claim by a Resolution Professional is Not Debt Acknowledgment  ||  Supreme Court: Public Figures Must Exercise Caution as Their Words Have Consequences in Society  ||  SC: State Must Act as a Model Employer, Criticising the Union For Not Regularising ISRO Workers    

Novartis Books Indian Patent for Skin Cancer Drug ‘Tafinlar’ - (21 Sep 2016)

Novartis AG has secured an Indian patent for its skin cancer drug Tafinlar, used in treatment of metastatic melanoma- the most serious and life-threatening type of skin cancer that is associated with low survival rates.

Tags : NOVARTIS   PATENT   TAFINLAR  

Share :        

Disclaimer | Copyright 2026 - All Rights Reserved